An open-label study on the safety and immunogenicity of a PD-1-enhanced DNA vaccine used as a T cell booster for COVID-19.
- DOI
- 10.1016/j.ebiom.2025.105699
- Published
- 2025 May
- Container
- EBioMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2025.105699,
title = {An open-label study on the safety and immunogenicity of a PD-1-enhanced DNA vaccine used as a T cell booster for COVID-19.},
author = {Wong YC and Hang Ho DH and Zhou R and Zhang R and Woo KF and Cheng WY and Wang T and Du Y and Polly Pang KP and Tai WK and Jin X and Chen Z and Ngai Hung IF},
year = {2025},
journal = {EBioMedicine},
doi = {10.1016/j.ebiom.2025.105699},
url = {https://doi.org/10.1016/j.ebiom.2025.105699}
}RIS
TY - JOUR TI - An open-label study on the safety and immunogenicity of a PD-1-enhanced DNA vaccine used as a T cell booster for COVID-19. AU - Wong YC AU - Hang Ho DH AU - Zhou R AU - Zhang R AU - Woo KF AU - Cheng WY AU - Wang T AU - Du Y AU - Polly Pang KP AU - Tai WK AU - Jin X AU - Chen Z AU - Ngai Hung IF PY - 2025 JO - EBioMedicine DO - 10.1016/j.ebiom.2025.105699 UR - https://doi.org/10.1016/j.ebiom.2025.105699 ER -
APA
YC, W., DH, H. H., R, Z., R, Z., KF, W., WY, C., T, W., Y, D., KP, P. P., WK, T., X, J., Z, C., & IF, N. H. (2025). An open-label study on the safety and immunogenicity of a PD-1-enhanced DNA vaccine used as a T cell booster for COVID-19.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2025.105699
Source records
- pubmed · retrieved 2026-09-26T23:35:23.847Z